Clinical trial
A Single-Arm, Prospective Study of Maintenance Therapy Cessation for Patients With Multiple Myeloma in Sustained MRD-Negative Remissions
NCT04221178 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Arm, Prospective Study of Maintenance Therapy Cessation for Patients With Multiple Myeloma in Sustained MRD-Negative Remissions
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 3, 2020
- Completion date
- January 3, 2027
- Enrollment
- 50 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
plasma cell myeloma